December 6, 2021 -- Silexon is partnering with Excelra, deploying Excelera's global online structure activity relationship (Gostar) database to strengthen its artificial intelligence (AI)-driven drug discovery and biopharmaceutical research platform.
Excelra will provide absorption, distribution, metabolism, and excretion data, as well as binding assay datasets, from its database to Silexon. Gostar's database includes information encompassing more than 8 million compounds and 28 million structure activity relationship-associated data points.
Silexon uses real-world biological data and machine-learning capabilities to aid in drug design. Silexon will use Gostar for drug discovery and biopharmaceutical research. This collaboration has the potential to shorten the time to market for new lifesaving drugs, according to the firms.
No financial terms of the agreement were disclosed.
Copyright © 2021 scienceboard.net